Identification of circulating microRNAs as biomarkers in cancers: what have we got?

References

1. Schwarzenbach H, Hoon DS, Pantel K. Cell-free nucleic acids as biomarkers in cancer patients. Nat Rev Cancer 2011;1:426–37.10.1038/nrc3066Search in Google Scholar PubMed

2. Kuhlmann JD, Rasch J, Wimberger P, Kasimir-Bauer S. microRNA and the pathogenesis of ovarian cancer – a new horizon for molecular diagnostics and treatment? Clin Chem Lab Med 2012;50:601–15.10.1515/cclm-2011-0847Search in Google Scholar PubMed

3. Markou A, Liang Y, Lianidou E. Prognostic, therapeutic and diagnostic potential of microRNAs in non-small cell lung cancer. Clin Chem Lab Med 2011;49:1591–603.10.1515/CCLM.2011.661Search in Google Scholar PubMed

4. Patnaik SK, Mallick R, Yendamuri S. Detection of microRNAs in dried serum blots. Anal Biochem 2010;407:147–9.10.1016/j.ab.2010.08.004Search in Google Scholar PubMed PubMed Central

5. Creemers EE, Tijsen AJ, Pinto YM. Circulating microRNAs: novel biomarkers and extracellular communications in cardiovascular disease? Circ Res 2012;110:483–95.10.1161/CIRCRESAHA.111.247452Search in Google Scholar PubMed

6. Lawrie CH, Gal S, Dunlop HM, Pushkaran B, Liggins AP, Pulford K, et al. Detection of elevated levels of tumour associated microRNAs in serum of patients with diffuse large B-cell lymphoma. Br J Haematol 2008;141:672–5.10.1111/j.1365-2141.2008.07077.xSearch in Google Scholar PubMed

7. Liu R, Chen X, Du Y, Yao W, Shen L, Wang C, et al. Serum microRNA expression profile as a biomarker in the diagnosis and prognosis of pancreatic cancer. Clin Chem 2012;5:610–8.10.1373/clinchem.2011.172767Search in Google Scholar PubMed

8. Wang H, Tan G, Dong L, Cheng L, Li K, Wang Z, et al. Circulating MiR-125b as a marker predicting chemoresistance in breast cancer. PLoS One 2012;7:e34210–7.10.1371/journal.pone.0034210Search in Google Scholar PubMed PubMed Central

9. McDonald JS, Milosevic D, Reddi HV, Grebe SK, Algeciras-Schimnich A. Analysis of circulating microRNA: preanalytical and analytical challenges. Clin Chem 2011;57:833–40.10.1373/clinchem.2010.157198Search in Google Scholar PubMed

10. Mitchell PS, Parkin RK, Kroh EM, Fritz BR, Wyman SK, Pogosova-Agadjanyan EL, et al. Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci USA 2008;105:10513–8.10.1073/pnas.0804549105Search in Google Scholar PubMed PubMed Central

11. Pigati L, Yaddanapudi SC, Iyengar R, Kim DJ, Hearn SA, Danforth D, et al. Selective release of microRNA species from normal and malignant mammary epithelial cells. PLoS One 2010;5:e13515–27.10.1371/journal.pone.0013515Search in Google Scholar PubMed PubMed Central

12. Kroh EM, Parkin RK, Mitchell PS, Tewari M. Analysis of circulating microRNA biomarkers in plasma and serum using quantitative reverse transcription-PCR (qRT-PCR). Methods 2010;50:298–301.10.1016/j.ymeth.2010.01.032Search in Google Scholar PubMed PubMed Central

13. Duttagupta R, Jiang R, Gollub J, Getts RC, Jones KW. Impact of cellular miRNAs on circulating miRNA biomarker signatures. PLoS One 2011;6:e20769–82.10.1371/journal.pone.0020769Search in Google Scholar PubMed PubMed Central

14. Schöler N, Langer C, Kuchenbauer F. Circulating microRNAs as biomarkers – true blood? Genome Med 2011;3:72–4.10.1186/gm288Search in Google Scholar PubMed PubMed Central

15. García-Giménez JL, Sanchis-Gomar F, Lippi G, Mena S, Ivars D, Gomez-Cabrera MC, et al. Epigenetic biomarkers: a new perspective in laboratory diagnostics. Clin Chim Acta 2012;413:1576–82.10.1016/j.cca.2012.05.021Search in Google Scholar PubMed

16. Rathjen T, Nicol C, McConkey G, Dalmay T. Analysis of short RNAs in the malaria parasite and its red blood cell host. FEBS Lett 2006;580:5185–8.10.1016/j.febslet.2006.08.063Search in Google Scholar PubMed

17. Chen SY, Wang Y, Telen MJ, Chi JT. The genomic analysis of erythrocyte microRNA expression in sickle cell diseases. PLoS One 2008;3:e2360–72.10.1371/journal.pone.0002360Search in Google Scholar PubMed PubMed Central

18. Sangokoya C, LaMonte G, Chi JT. Isolation and characterization of microRNAs of human mature erythrocytes. Methods Mol Biol 2010;667:193–203.10.1007/978-1-60761-811-9_13Search in Google Scholar PubMed PubMed Central

19. Heneghan HM, Miller N, Lowery AJ, Sweeney KJ, Newell J, Kerin MJ. Circulating microRNAs as novel minimally invasive biomarkers for breast cancer. Ann Surg 2010;251:499–505.10.1097/SLA.0b013e3181cc939fSearch in Google Scholar PubMed

20. Schrauder MG, Strick R, Schulz-Wendtland R, Strissel PL, Kahmann L, Loehberg CR, et al. Circulating micro-RNAs as potential blood-based markers for early stage breast cancer detection. PLoS One 2012;7:e29770–8.10.1371/journal.pone.0029770Search in Google Scholar PubMed PubMed Central

21. Häusler SF, Keller A, Chandran PA, Ziegler K, Zipp K, Heuer S, et al. Whole blood-derived miRNA profiles as potential new tools for ovarian cancer screening. Br J Cancer 2010;103:693–700.10.1038/sj.bjc.6605833Search in Google Scholar PubMed PubMed Central

22. Keller A, Leidinger P, Bauer A, Elsharawy A, Haas J, Backes C, et al. Toward the blood-borne miRNome of human diseases. Nat Methods 2011;8:841–3.10.1038/nmeth.1682Search in Google Scholar PubMed

23. Heneghan HM, Miller N, Kelly R, Newell J, Kerin MJ. Systemic miRNA-195 differentiates breast cancer from other malignancies and is a potential biomarker for detecting non-invasive and early stage disease. Oncologist 2010;15:673–82.10.1634/theoncologist.2010-0103Search in Google Scholar PubMed PubMed Central

24. Leidinger P, Keller A, Borries A, Reichrath J, Rass K, Jager SU, et al. High-throughput miRNA profiling of human melanoma blood samples. BMC Cancer 2010;10:262–72.10.1186/1471-2407-10-262Search in Google Scholar PubMed PubMed Central

25. Heneghan HM, Miller N, Kerin MJ. Systemic microRNAs: novel biomarkers for colorectal and other cancers? Gut 2010;59:1002–4.10.1136/gut.2009.200121Search in Google Scholar PubMed

26. Chen X, Ba Y, Ma L, Cai X, Yin Y, Wang K, et al. Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases. Cell Res 2008;18:997–1006.10.1038/cr.2008.282Search in Google Scholar PubMed

27. Wang F, Zheng Z, Guo J, Ding X. Correlation and quantification of microRNA aberrant expression in tissues and sera from patients with breast tumor. Gynecol Oncol 2010;119: 286–93.10.1016/j.ygyno.2010.07.021Search in Google Scholar PubMed

28. Asaga S, Kuo C, Nguyen T, Terpenning M, Giuliano AE, Hoon DS. Direct serum assay for microRNA-21 concentrations in early and advanced breast cancer. Clin Chem 2011;57:84–91.10.1373/clinchem.2010.151845Search in Google Scholar PubMed

29. Zhao H, Shen J, Medico L, Wang D, Ambrosone CB, Liu S. A pilot study of circulating miRNAs as potential biomarkers of early stage breast cancer. PLoS One 2010;5:e13735–46.10.1371/journal.pone.0013735Search in Google Scholar PubMed PubMed Central

30. Brase JC, Wutting D, Kuner R, Sültmann H. Serum microRNAs as non-invasive biomarkers for cancer. Mol Cancer 2010;9:306–14.10.1186/1476-4598-9-306Search in Google Scholar PubMed PubMed Central

31. Turchinovich A, Weiz L, Langheinz A, Burwinkel B. Characterization of extracellular circulating microRNA. Nucleic Acids Res 2011;39:7223–33.10.1093/nar/gkr254Search in Google Scholar PubMed PubMed Central

32. Ohshima K, Inoue K, Fujiwara A, Hatakeyama K, Kanto K, Watanabe Y, et al. Let-7 microRNA family is selectively secreted into the extracellular environment via exosomes in a metastatic gastric cancer cell line. PloS One 2010;5:e13247–56.10.1371/journal.pone.0013247Search in Google Scholar PubMed PubMed Central

33. Gallo A, Tandon M, Alevizos I, Illei GG. The majority of microRNAs detectable in serum and saliva is concentrated in exosomes. PLoS One 2012;7:e30679–83.10.1371/journal.pone.0030679Search in Google Scholar PubMed PubMed Central

34. Valadi H, Ekström K, Bossios A, Sjöstrand M, Lee JJ, Lötvall JO. Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat Cell Biol 2007;9:654–9.10.1038/ncb1596Search in Google Scholar PubMed

35. Kosaka N, Iguchi H, Yoshioka Y, Takeshita F, Matsuki Y, Ochiya T. Secretory mechanisms and intercellular transfer of microRNAs in living cells. J Biol Chem 2010;285:17442–52.10.1074/jbc.M110.107821Search in Google Scholar PubMed PubMed Central

36. Taylor DD, Gercel-Taylor C. MicroRNA signatures of tumor-derived exosomes as diagnostic biomarkers of ovarian cancer. Gynecol Oncol 2008;110:13–21.10.1016/j.ygyno.2008.04.033Search in Google Scholar PubMed

37. Pritchard CC, Kroh E, Wood B, Arroyo JD, Dougherty KJ, Miyaji MM, et al. Blood cell origin of circulating microRNAs: a cautionary note for cancer biomarker studies. Cancer Prev Res (Phila) 2012;5:492–7.10.1158/1940-6207.CAPR-11-0370Search in Google Scholar PubMed PubMed Central

38. Liu J, Gao J, Du Y, Li Z, Ren Y, Gu J, et al. Combination of plasma microRNAs with serum CA19-9 for early detection of pancreatic cancer. Int J Cancer 2011;131:683–91.10.1002/ijc.26422Search in Google Scholar PubMed

39. Wang J, Chen J, Chang P, LeBlanc A, Li D, Abbruzzesse JL, et al. MicroRNAs in plasma of pancreatic ductal adenocarcinoma patients as novel blood-based biomarkers of disease. Cancer Prev Res (Phila) 2009;2:807–13.10.1158/1940-6207.CAPR-09-0094Search in Google Scholar PubMed PubMed Central

40. Tsujiura M, Ichikawa D, Komatsu S, Shiozaki A, Takeshita H, Kosuga T, et al. Circulating microRNAs in plasma of patients with gastric cancer. Br J Cancer 2010;102:1174–9.10.1038/sj.bjc.6605608Search in Google Scholar PubMed PubMed Central

41. Resnick KE, Alder H, Hagan JP, Richardson DL, Croce CM, Cohn DE. The detection of differentially expressed microRNAs from the serum of ovarian cancer patients using a novel real-time PCR platform. Gynecol Oncol 2009;112:55–9.10.1016/j.ygyno.2008.08.036Search in Google Scholar PubMed

42. Shen J, Todd NW, Zhang H, Yu L, Lingxiao X, Mei Y, et al. Plasma microRNAs as potential biomarkers for non-small-cell lung cancer. Lab Invest 2011;91:579–87.10.1038/labinvest.2010.194Search in Google Scholar PubMed PubMed Central

43. Shen J, Liu Z, Todd NW, Zhang H, Liao J, Yu L, et al. Diagnosis of lung cancer in individuals with solitary pulmonary nodules by plasma microRNA biomarkers. BMC Cancer 2011;11:374–82.10.1186/1471-2407-11-374Search in Google Scholar PubMed PubMed Central

44. Wang ZX, Bian HB, Wang JR, Cheng ZX, Wang KM, De W. Prognostic significance of serum miRNA-21 expression in human non-small cell lung cancer. J Surg Oncol 2011;104:847–51.10.1002/jso.22008Search in Google Scholar PubMed

45. Tomimaru Y, Equchi H, Nagano H, Wada H, Kobayashi S, Marubashi S, et al. Circulating microRNA-21 as a novel biomarker for hepatocellular carcinoma. J Hepatol 2012;56:167–75.10.1016/j.jhep.2011.04.026Search in Google Scholar PubMed

46. Xu J, Wu C, Che X, Wang L, Yu D, Zhang T, et al. Circulating microRNAs, miR-21, miR-122, and miR-233, in patients with hepatocellular carcinoma or chronic hepatitis. Mol Carcinog 2011;50:136–42.10.1002/mc.20712Search in Google Scholar PubMed

47. Bihrer V, Waidmann O, Friedrich-Rust M, Forestier N, Susser S, Haupenthal J, et al. Serum microRNA-21 as marker for necroinflammation in hepatitis C patients with and without hepatocellular carcinoma. PLoS One 2011;6:e26971–7.10.1371/journal.pone.0026971Search in Google Scholar PubMed PubMed Central

48. Qi P, Cheng SQ, Wang H, Li N, Chen YF, Gao CF. Serum microRNAs as biomarkers for hepatocellular carcinoma in Chinese patients with chronic hepatitis B virus infection. PLoS One 2011;e28486–93.10.1371/journal.pone.0028486Search in Google Scholar PubMed PubMed Central

49. Komatsu S, Ichikawa D, Takeshita H, Tsujiura M, Morimura R, Nagata H, et al. Circulating microRNAs in plasma of patients with oesophageal squamous cell carcinoma. Br J Cancer 2011;105:104–11.10.1038/bjc.2011.198Search in Google Scholar PubMed PubMed Central

50. Zhang HL, Yang LF, Zhu Y, Yao XD, Zhang SL, Dai B, et al. Serum miRNA-21: elevated levels in patients with metastatic hormone-refractory prostate cancer and potential predictive factor for the efficacy of docetaxel-based chemotherapy. Prostate 2011;71:326–31.10.1002/pros.21246Search in Google Scholar PubMed

51. Shen J, Hruby GW, McKiernan JM, Gurvich I, Lipsky MJ, Benson MC, et al. Dysregulation of circulating microRNAs and prediction of aggressive prostate cancer. Prostate 2012;72:1469–77.10.1002/pros.22499Search in Google Scholar PubMed PubMed Central

52. Paraskevi A, Theodoropoulos G, Papaconstantinou I, Mantzaris G, Nikiteas N, Gazouli M. Circulating MicroRNA in inflammatory bowel disease. J Crohns Colitis 2012. 2012 Feb 28 [Epub ahead of print]. DOI: 10.1016/j.crohns.2012.02.006.10.1016/j.crohns.2012.02.006Search in Google Scholar PubMed

53. Lagos-Quintana M, Rauhut R, Yalcin A, Meyer J, Lendeckel W, Tuschl T. Identification of tissue-specific microRNAs from mouse. Curr Biol 2002;12:735–9.10.1016/S0960-9822(02)00809-6Search in Google Scholar PubMed

54. Zhang Y, Jia Y, Zheng R, Guo Y, Wang Y, Guo H, et al. Plasma microRNA-122 as a biomarker for viral-, alcohol-, and chemical-related hepatic diseases. Clin Chem 2010;56:1830–8.10.1373/clinchem.2010.147850Search in Google Scholar PubMed

55. Starkey Lewis PJ, Dear J, Platt V, Simpson KJ, Craig DG, Antoine DJ, et al. Circulating microRNAs as potential markers of human drug-induced liver injury. Hepatology 2011;54:1767–76.10.1002/hep.24538Search in Google Scholar PubMed

56. Wang K, Zhang S, Marzolf B, Troisch P, Brightman A, Hu Z, et al. Circulating microRNAs, potential biomarkers for drug-induced liver injury. Proc Natl Acad Sci USA 2009;106:4402–7.10.1073/pnas.0813371106Search in Google Scholar PubMed PubMed Central

57. Appaiah HN, Goswami CP, Mina LA, Badve S, Sledge GW, Liu Y, et al. Persistent upregulation of U6:SNORD44 small RNA ratio in the serum of breast cancer patients. Breast Cancer Res 2011;13:R86–95.10.1186/bcr2943Search in Google Scholar PubMed PubMed Central

58. Lodes MJ, Caraballo M, Suciu D, Munro S, Kumar A, Anderson B. Detection of cancer with serum miRNAs on an oligonucleotide microarray. PloS One 2009;4:e6229–40.10.1371/journal.pone.0006229Search in Google Scholar PubMed PubMed Central

59. Cermelli S, Ruggieri A, Marrero JA, Ioannou GN, Beretta L. Circulating microRNAs in patients with chronic hepatitis C and non-alcoholic fatty liver disease. PLoS One 2011;6:e23937–44.10.1371/journal.pone.0023937Search in Google Scholar PubMed PubMed Central

60. Mahn R, Heukamp LC, Rogenhofer S, von Ruecker A, Müller SC, Ellinger J. Circulating microRNAs (miRNA) in serum of patients with prostate cancer. Urology 2011;77:1265.e9–16.10.1016/j.urology.2011.01.020Search in Google Scholar PubMed

61. Hu Z, Dong J, Wang LE, Ma H, Liu J, Zhao Y, et al. Serum microRNA profiling and breast cancer risk: the use of miR-484/191 as endogenous controls. Carcinogenesis 2012;33:828–34.10.1093/carcin/bgs030Search in Google Scholar PubMed

62. Qu KZ, Zhang K, Li H, Afdhal NH, Albitar M. Circulating microRNAs as biomarkers for hepatocellular carcinoma. J Clin Gastroenterol 2011;45:355–60.10.1097/MCG.0b013e3181f18ac2Search in Google Scholar PubMed

63. Zhu HT, Dong QZ, Wang G, Zhou HJ, Ren N, Jia HL, et al. Identification of suitable reference genes for qRT-PCR analysis of circulating microRNAs in hepatitis B virus-infected patients. Mol Biotechnol 2012;50:49–56.10.1007/s12033-011-9414-6Search in Google Scholar PubMed

64. Song J, Bai Z, Han W, Zhang J, Meng H, Bi J, et al. Identification of suitable reference genes for qPCR analysis of serum microRNA in gastric cancer patients. Dig Dis Sci 2012;57:897–904.10.1007/s10620-011-1981-7Search in Google Scholar PubMed

65. Kim DJ, Linnstaedt S, Palma J, Park JC, Ntrivalas E, Kwak-Kim JY, et al. Plasma components affect accuracy of circulating cancer-related microRNA quantitation. J Mol Diagn 2012; 14:71–80.10.1016/j.jmoldx.2011.09.002Search in Google Scholar PubMed PubMed Central

66. Heneghan HM, Miller N, Kerin MJ. Circulating microRNAs: promising breast cancer Biomarkers. Breast Cancer Res 2011;13:402.10.1186/bcr2798Search in Google Scholar PubMed PubMed Central

67. Zernecke A, Bidzhekov K, Noels H, Shagdarsuren E, Gan L, Benecke B, et al. Delivery of microRNA-126 by apoptotic bodies induces CXCL 12-dependent vascular protection. Sci Signal 2009;2:ra81.10.1126/scisignal.2000610Search in Google Scholar PubMed

68. Novellino L, Rossi RL, Bonino F, Cavallone D, Abrignani S, Pagani M, et al. Circulating Hepatitis B surface antigen particles carry hepatocellular microRNAs. PloS One 2012;7:e31952–61.10.1371/journal.pone.0031952Search in Google Scholar PubMed PubMed Central

69. Vickers KC, Palmisano BT, Shoucri BM, Shamburek RD, Remaley AT. MicroRNAs are transported in plasma and delivered to recipient cells by high-density lipoproteins. Nat Cell Biol 2011;13:423–33.10.1038/ncb2210Search in Google Scholar PubMed PubMed Central

70. Arroyo JD, Chevillet JR, Kroh EM, Ruf IK, Pritchard CC, Gibson DF, et al. Argonaute2 complexes carry a population of circulating microRNAs independent of vesicles in human plasma. Proc Natl Acad Sci USA 2011;108:5003–8.10.1073/pnas.1019055108Search in Google Scholar PubMed PubMed Central

71. Heegaard NH, Schetter AJ, Welsh JA, Yoneda M, Bowman ED, Harris CC. Circulating micro-RNA expression profiles in early stage non-small cell lung cancer. Int J Cancer 2012;130:1378–86.10.1002/ijc.26153Search in Google Scholar PubMed PubMed Central

72. Baggish AL, Hale A, Weiner RB, Lewis GD, Systrom D, Wang F, et al. Dynamic regulation of circulating microRNA during acute exhaustive exercise and sustained aerobic exercise training. J Physiol 2011;589:3983–94.10.1113/jphysiol.2011.213363Search in Google Scholar PubMed PubMed Central

73. Etheridge A, Lee I, Hood L, Galas D, Wang K. Extracellular microRNA: a new source of biomarkers. Mutat Res 2011; 717:85–90.10.1016/j.mrfmmm.2011.03.004Search in Google Scholar PubMed PubMed Central